The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

During a roughly five-year span, CVS Health, Cigna, and UnitedHealth benefited the most from increasing prices for generic drugs that treated illnesses such as HIV and cancer. Some of the price hikes ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Jezebel has been the Internet's most treasured source for everything celebrities, sex, and politics...with teeth.

For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that from 2021 to 2023, those rates dropped from 41.9% to 40.3%.

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

From heart and kidney health to addiction reduction, GLP-1 drugs like Ozempic and Mounjaro may help with more than just weight loss Steve Christo/Corbis/Corbis/Getty ...